Overall Survival Study and Prevalence of MYD88 Protein Expression by Immunohistochemistry in Diffuse Large B Cell Lymphoma: A Retrospective Cohort Study
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), characterized by clinical and molecular heterogeneity. Genetic alterations in signaling pathways, especially the MYD88 gene, have been implicated in disease progression and prognosis. Although MYD88 protein expre...